The clinical features of takotsubo cardiomyopathy

QJM: An International Journal of Medicine

Volumn 96, Issue 8, 2003, Pages 563-573

  Akashi, Y Johnny ^a   Nakazawa, K ^a   Sakakibara, M ^a   Miyake, F ^a   Koike, H ^a   Sasaka, K ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORPHENIRAMINE MALEATE; CREATINE KINASE ISOENZYME; CREATINE KINASE MB; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; FAMOTIDINE; MAGNESIUM SULFATE; MAPROTILINE; METOPROLOL; NIFEDIPINE; NORADRENALIN; PILSICAINIDE; PRAVASTATIN; PROCATEROL; RILMAZAFONE; THEOPHYLLINE; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY SPASM; CREATINE KINASE BLOOD LEVEL; DEMENTIA; DEPRESSION; DISEASE COURSE; ELECTROCARDIOGRAM; EMPHYSEMA; ENDOCARDIAL BIOPSY; FEMALE; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HEART VENTRICULOGRAPHY; HUMAN; HYPERTENSION; MALE; MYOCARDITIS; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0042023675     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hcg096     Document Type: Article

References (41)

1. Kuramoto K, Matsushita S, Murakami M. Acute reversible myocardial infarction after blood transfusion in the aged. Jpn Heart J 1977; 18:191-201.
2. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66:1146-9.
3. Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol 1991; 21:203-14.
4. Iga K, Hori K, Kitaguchi K, Matsumura T, Gen H, Tomonaga G, Tamamura T. Transient segmental asynergy of the left ventricle of patients with various clinical manifestations possibly unrelated to the coronary artery disease. Jpn Circ J 1991; 55:1061-7.
5. Salathe M, Weiss P, Ritz R. Rapid reversible of heart failure in a patient with phaeochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril. Br Heart J 1992; 68:527-8.
6. Yamanaka O, Fujisawa Y, Nakamura T, Ohno A, Endo Y, Yoshimi K, Miura K, Yamaguchi H. 'Myocardial stunning'-like phenomenon during a crisis of pheochromocytoma. Jpn Circ J 1994; 58:737-42.
7. Scott IU, Guttermann DD. Pheochromocytoma with reversible focal cardiac dysfunction. Am Heart J 1995; 130:909-11.
8. Iga K, Himura Y, Izumi C, Miyamoto T, Kijima K, Gen H, Konishi T. Reversible left ventricular dysfunction associated with Guillain-Barré syndrome: An expression of catechoramine cardiotoxicity? Jpn Circ J 1995; 59:236-40.
9. Brandspiegel HZ, Marinchak RA, Kowey PR. A broken heart. Circulation 1998; 98:1349.
10. Goldman LE, Sahlas DJ, Sami M. A case of thyrotoxicosis and reversible systolic cardiac dysfunction. Can J Cardiol 1999; 15:811-14.
11. Lee C, Wolfe KB, Rabson JL. Reversible biventricular dysfunction secondary to ischemia in a patient with acute airway obstruction: a case report and review of the literature on reversible causes of acute ventricular dysfunction. Can J Cardiol 1999; 15:705-8.
12. Kawasaki T, Ito K, Okano A, Nagata K, Okamoto A, Yoneyama S, Katoh S. A dynamic change by 1231-15-(plodophenyl)-3-R, S-Methyl pentadecanoic acid myocardial single photon emission computed tomography in a 55-years-old woman. Jpn Circ J 1999; 63:732-6.
13. Mitsuya N, Akashi Y, Ozawa Y, Ando H, Nagashima J, Sakakibara M, Tochiki H, Nobuoka S, Nakazawa K, Miyake F. A case of transient left ventricular dysfunction so called takotsubo-like wall motion abnormality that appeared to be caused by acute myocarditis. Ther Res 1999; 20:80-5.
14. Kawai S, Suzuki H, Yamaguchi H, Tanaka K, Sawada H, Aizawa T, Watanabe M, Tamura T, Umawatari K, Kawada M, Nakamura T, Yamanaka O, Okada R. Ampulla cardiomyopathy ('Takotsubo' cardiomyopathy): Reversible left ventricular dysfunction with ST segment elevation. Jpn Circ J 2000; 64:156-9.
15. Owa M, Aizawa K, Urasawa N, Ichinose H, Yamamoto K, Karasawa K, Kagoshima M, Koyama J, Ikeda S. Emotional stress-induced 'ampulla cardiomyopathy': discrepancy between the metabolic and sympathetic innervation imaging performed during the recovery course. Jpn Circ J 2001; 65:349-52.
16. Kurisu S, Sato H, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Kono Y, Umemura T, Nakamura S. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J, 2002; 143:448-55.
17. Akashi YJ, Sakakibara M, Miyake F. Reversible left ventricular dysfunction 'takotsubo' cardiomyopathy associated with pneumothorax. Heart 2002; 87:E1.
18. Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Sasaka K. Reversible left ventricular dysfunction 'takotsubo' cardiomyopathy related to catecholamine cardiotoxicity. J Electrocardiol 2002; 35:351-6.
19. Akashi YJ, Nakazawa K, Kida K, Ryu S, Takagi A, Kishi R, Kunishima T, Masayoshi S, Miyake F. Reversible ventricular dysfunction (takotsubo cardiomyopathy) following polymorphic ventricular tachycardia. Can J Cardiol 2003; 19:449-51.
20. Simons M, Downing SE. Coronary vasoconstriction and catecholamine cardiomyopathy. Am Heart J 1985; 109: 297-304.
21. Frustaci Q, Loperfido F, Gentiloni N, Caldarulo M, Morgante E, Russo MA. Catecholamine-induced cardiomyopathy in multiple endocrine neoplasia: A histologic, ultrastructural, and biochemical study. Chest 1991; 99:382-5.
22. Yamabe H, Hanaoka J, Funakoshi T, Iwahashi M, Takeuchi M, Saito K, Kawashima S, Yokoyama M. Deep negative T waves and abnormal cardiac sympathetic image (123 I-MIBG) after the great Hanshin earthquake of 1995. Am J Med Sci 1996; 311:221-4.
23. Cebelin MS, Hirsch CS. Human stress cardiomyopathy: Myocardial lesions in victims of homicidal assaults without internal injuries. Hum Path 1980; 11:123-32.
24. Pollick C, Cujec B, Parker S, Tator C. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echocardiographic study. J Am Coll Cardiol 1988; 12:600-5.
25. Sakamoto H, Nishimura H, Imataka K, Ieki K, Horie T, Fujii J. Abnormal Q wave, ST-segment elevation, T-wave inversion, and widespread focal myocytolysis associated with subarachnoid hemorrhage. Jpn Circ J 1996; 60:254-7.
26. Ueyama T, Yoshida K, Senba E. Stress-induced elevation of the ST segment in the rat electrocardiogram is normalized by an adrenoceptor blocker. Clin Exp Pharmacol Physiol 2000; 27:384-6.
27. Mann D, Kent RL, Parsons B, Cooper G 4th. Adrenergic effects on the biology of the adult mammalian cadiocyte. Circulation 1992; 85:790-804.
28. White M, Wiechmann RJ, Roden RL, Hagan MB, Wollmering MM, Port JD, Hammond E, Abraham WT, Wolfel EE, Lindenfeld J, Fullerton D, Bristow MR. Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Circulation 1995; 92:2183-9.
29. Novitzky D, Wicomb WN, Cooper DK, Rose AG, Reichart B. Prevention of myocardial injury during brain death by total cardiac sympathectomy in the Chacma baboon. Ann Thorac Surg 1986; 41:520-4.
30. Ueyama T, Kasamatsu K, Hano T, Yamamoto K, Tsuruo Y, Nishio I. Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors. Circ J 2002; 66:712-13.
31. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M. Attenuation of compensation of endogeneous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96:509-16.
32. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptides a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135:825-32.
33. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28:988-94.
34. Kloner RA, Przyklenk K, Patel B. Altered myocardial states. The stunned and hibernating myocardium. Am J Med 1989; 86(1A):14-22.
35. Todd GL, Baroldi G, Pieper GM, Clayton FC, Eliot RS. Experimental catecholamine-induced myocardial necrosis. II. Temporal development of isoproterenol-induced myocardial contraction band lesions correlated with ECG, hemodynamic, and biochemical changes. J Mol Cell Cardiol 1985; 17:647-56.
36. Poole-Wilson PA, Krake T. The enigma of syndrome X. Int J Microcirc 1989; 8:423-32.
37. Maseri A, Crea F, Kasai JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991; 17:499-506
38. Rosano GM, Lindsay D, Kasai JC, Sarrel P, Poole-Wilson P. Syndrome X in women: The importance of ovarian hormone. J Am Coll Cardiol 1992; 19:255A.
39. Rosano GM, Ponikowski P, Adamopoulos S, Collons P, Poole-Wilson PA, Coats AJ, Kaski JC. Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol 1994; 73:1174-9.
40. Kasai JC, Elliot PM. Angina pectoris and normal coronary arteriogram: Clinical presentation and hemodynamics characteristics. Am J Cardiol 1995; 76:35D-42D.
41. Murakami H, Urabe K, Nishimura M. Inappropriate microvascular constriction produced transient ST-segment elevation patients with syndrome X. J Am Coll Cardiol 1998; 32:1287-94.